JB
Jason Bednar Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
49
Avg Return
Past Year
Past Year
0.83%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
65.5%
Neutral
34.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Medical Devices
Medical Distribution
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Downgraded
| $5 |
44%
downside
| 1 | – |
–
| 4 Mar ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $178 |
36%
upside
| 4 | +4% |
0
%
| 20 Feb ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $106 |
74%
upside
| 6 | -4.2% |
0
%
| 18 Feb ‘26 3 months ago |
|
|
|
Neutral
Reiterated
| $170 |
18%
upside
| 6 | -15% |
0
%
| 10 Feb ‘26 3 months ago |
|
|
|
Neutral
Reiterated
| $25 |
9%
upside
| 4 | – |
–
| 6 Feb ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $220 |
32%
upside
| 5 | +2% |
0
%
| 5 Feb ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $94 |
52%
upside
| 1 | -8.7% |
0
%
| 30 Jan ‘26 4 months ago |
|
|
|
Overweight
Initiated
| $50 |
51%
upside
| 1 | +2.8% |
0
%
| 12 Jan ‘26 4 months ago |
|
|
|
Overweight
Upgraded
| $24 |
60%
upside
| 3 | -27% |
0
%
| 9 Jan ‘26 4 months ago |
|
|
|
Overweight
Reiterated
| $94 |
58%
upside
| 3 | -3.6% |
0
%
| 5 Dec ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $98 |
28%
upside
| 5 | -3.1% |
0
%
| 7 Nov ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $210 |
17%
upside
| 2 | +4.3% |
0
%
| 6 Aug ‘25 10 months ago |
|
|
|
Neutral
Downgraded
| $2.50 |
55%
upside
| 2 | -35% |
0
%
| 31 Jul ‘25 10 months ago |
|
|
|
Overweight
Reiterated
| $34 |
115%
upside
| 2 | -12% |
0
%
| 27 Jun ‘25 11 months ago |
|